Terms: = Bone cancer AND SRSF2, Q01130, 6427, SFRS2
95 results:
1. A novel t(X;21)(p11.4;q22.12) translocation adds to the role of BCOR and RUNX1 in myelodysplastic syndromes and acute myeloid leukemias.
Mavridou E; Lema Fernandez AG; Nardelli C; Pierini V; Quintini M; Arniani S; Di Giacomo D; Crescenzi B; Matteucci C; Sambani C; Mecucci C
Genes Chromosomes Cancer; 2024 Apr; 63(4):e23235. PubMed ID: 38656651
[TBL] [Abstract] [Full Text] [Related]
2. Caspase 8 deletion causes infection/inflammation-induced bone marrow failure and MDS-like disease in mice.
Liu S; Joshi K; Zhang L; Li W; Mack R; Runde A; Hagen PA; Barton K; Breslin P; Ji HL; Kini AR; Wang Z; Zhang J
Cell Death Dis; 2024 Apr; 15(4):278. PubMed ID: 38637559
[TBL] [Abstract] [Full Text] [Related]
3. Predicting cytopenias, progression, and survival in patients with clonal cytopenia of undetermined significance: a prospective cohort study.
Cargo C; Bernard E; Beinortas T; Bolton KL; Glover P; Warren H; Payne D; Ali R; Khan A; Short M; Van Hoppe S; Smith A; Taylor J; Evans P; Papaemmanuil E; Crouch S
Lancet Haematol; 2024 Jan; 11(1):e51-e61. PubMed ID: 38135373
[TBL] [Abstract] [Full Text] [Related]
4. Cutaneous Manifestations of Myeloid Neoplasms Exhibit Broad and Divergent Morphologic and Immunophenotypic Features but Share Ancestral Clonal Mutations With bone Marrow.
Sadigh S; DeAngelo DJ; Garcia JS; Hasserjian RP; Hergott CB; Lane AA; Lovitch SB; Lucas F; Luskin MR; Morgan EA; Pinkus GS; Pozdnyakova O; Rodig SJ; Shanmugam V; Tsai HK; Winer ES; Zemmour D; Kim AS
Mod Pathol; 2024 Jan; 37(1):100352. PubMed ID: 37839675
[TBL] [Abstract] [Full Text] [Related]
5. Spliceosome mutations are associated with clinical response in a phase 1b/2 study of the PLK1 inhibitor onvansertib in combination with decitabine in relapsed or refractory acute myeloid leukemia.
Croucher PJP; Ridinger M; Becker PS; Lin TL; Silberman SL; Wang ES; Zeidan AM
Ann Hematol; 2023 Nov; 102(11):3049-3059. PubMed ID: 37702821
[TBL] [Abstract] [Full Text] [Related]
6. Diagnosis- and Prognosis-Related Gene Alterations in
Morishita S; Komatsu N
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629188
[No Abstract] [Full Text] [Related]
7. Allogeneic Hematopoietic Cell Transplantation Improves Outcome in Myelodysplastic Syndrome Across High-Risk Genetic Subgroups: Genetic Analysis of the Blood and Marrow Transplant Clinical Trials Network 1102 Study.
Versluis J; Saber W; Tsai HK; Gibson CJ; Dillon LW; Mishra A; McGuirk J; Maziarz RT; Westervelt P; Hegde P; Mukherjee D; Martens MJ; Logan B; Horowitz M; Hourigan CS; Nakamura R; Cutler C; Lindsley RC;
J Clin Oncol; 2023 Oct; 41(28):4497-4510. PubMed ID: 37607457
[TBL] [Abstract] [Full Text] [Related]
8. Integrated Genomic and Transcriptomic Analysis Improves Disease Classification and Risk Stratification of MDS with Ring Sideroblasts.
Todisco G; Creignou M; Bernard E; Björklund AC; Moura PL; Tesi B; Mortera-Blanco T; Sander B; Jansson M; Walldin G; Barbosa I; Reinsbach SE; Hofman IJ; Nilsson C; Yoshizato T; Dimitriou M; Chang D; Olafsdottir S; Venckute Larsson S; Tobiasson M; Malcovati L; Woll P; Jacobsen SEW; Papaemmanuil E; Hellström-Lindberg E
Clin Cancer Res; 2023 Oct; 29(20):4256-4267. PubMed ID: 37498312
[TBL] [Abstract] [Full Text] [Related]
9. Co-occurring mutations in ASXL1, srsf2, and SETBP1 define a subset of myelodysplastic/ myeloproliferative neoplasm with neutrophilia.
Jain T; Ware AD; Dalton WB; Pasca S; Tsai HL; Gocke CD; Gondek LP; Xian RR; Borowitz MJ; Levis MJ
Leuk Res; 2023 Aug; 131():107345. PubMed ID: 37354804
[TBL] [Abstract] [Full Text] [Related]
10. Triple-Negative Primary Myelofibrosis: A bone Marrow Pathology Group Study.
Al-Ghamdi YA; Lake J; Bagg A; Thakral B; Wang SA; Bueso-Ramos C; Masarova L; Verstovsek S; Rogers HJ; Hsi ED; Gralewski JH; Chabot-Richards D; George TI; Rets A; Hasserjian RP; Weinberg OK; Parilla M; Arber DA; Padilla O; Orazi A; Tam W
Mod Pathol; 2023 Mar; 36(3):100016. PubMed ID: 36788093
[TBL] [Abstract] [Full Text] [Related]
11. Venetoclax in combination with hypomethylating agent for the treatment of advanced myeloproliferative neoplasms and acute myeloid leukemia with extramedullary disease.
Sanber K; Ye K; Tsai HL; Newman M; Webster JA; Gojo I; Ghiaur G; Prince GT; Gondek LP; Smith BD; Levis MJ; DeZern AE; Ambinder AJ; Dalton WB; Jain T
Leuk Lymphoma; 2023 Apr; 64(4):846-855. PubMed ID: 36744656
[TBL] [Abstract] [Full Text] [Related]
12. Alterations of cohesin complex genes in acute myeloid leukemia: differential co-mutations, clinical presentation and impact on outcome.
Eckardt JN; Stasik S; Röllig C; Sauer T; Scholl S; Hochhaus A; Crysandt M; Brümmendorf TH; Naumann R; Steffen B; Kunzmann V; Einsele H; Schaich M; Burchert A; Neubauer A; Schäfer-Eckart K; Schliemann C; Krause SW; Herbst R; Hänel M; Hanoun M; Kaiser U; Kaufmann M; Rácil Z; Mayer J; Cerqueira T; Kroschinsky F; Berdel WE; Serve H; Müller-Tidow C; Platzbecker U; Baldus CD; Schetelig J; Siepmann T; Bornhäuser M; Middeke JM; Thiede C
Blood Cancer J; 2023 Jan; 13(1):18. PubMed ID: 36693840
[TBL] [Abstract] [Full Text] [Related]
13. Molecular response patterns in relapsed/refractory AML patients treated with selinexor and chemotherapy.
Klement P; Fiedler W; Gabdoulline R; Dallmann LK; Wienecke CP; Schiller J; Kandziora C; Teich K; Heida B; Büttner K; Brandes M; Funke C; Wichmann M; Othman B; Chromik J; Amberg S; Kebenko M; Schlipfenbacher V; Wilke AC; Modemann F; Janning M; Serve H; Bokemeyer C; Theile S; Deppermann U; Kranich AL; Ganser A; Thol F; Heuser M
Ann Hematol; 2023 Feb; 102(2):323-328. PubMed ID: 36576532
[TBL] [Abstract] [Full Text] [Related]
14. Hitting the brakes on accelerated and blast-phase myeloproliferative neoplasms: current and emerging concepts.
Bewersdorf JP; Rampal RK
Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):218-224. PubMed ID: 36485103
[TBL] [Abstract] [Full Text] [Related]
15. Accelerated and blast phase myeloproliferative neoplasms.
Saliba AN; Gangat N
Best Pract Res Clin Haematol; 2022 Jun; 35(2):101379. PubMed ID: 36333070
[TBL] [Abstract] [Full Text] [Related]
16. JAK2V617F variant allele frequency, non-driver mutations, single-nucleotide variants and polycythemia vera outcome.
Kanduła Z; Janowski M; Więckowska B; Paczkowska E; Lewandowski K
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4789-4803. PubMed ID: 36242602
[TBL] [Abstract] [Full Text] [Related]
17. Allogeneic hematopoietic cell transplantation can overcome the adverse prognosis indicated by secondary-type mutations in de novo acute myeloid leukemia.
Song GY; Kim T; Ahn SY; Jung SH; Kim M; Yang DH; Lee JJ; Choi SH; Kim MY; Jung CW; Jang JH; Kim HJ; Moon JH; Sohn SK; Won JH; Park SK; Kim SH; Zhang Z; Ahn JS; Kim HJ; Kim DDH
Bone Marrow Transplant; 2022 Dec; 57(12):1810-1819. PubMed ID: 36151367
[TBL] [Abstract] [Full Text] [Related]
18. Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM Registry.
Kennedy VE; Perkins C; Reiter A; Jawhar M; Lübke J; Kluin-Nelemans HC; Shomali W; Langford C; Abuel J; Hermine O; Niedoszytko M; Gorska A; Mital A; Bonadonna P; Zanotti R; Tanasi I; Mattsson M; Hagglund H; Triggiani M; Yavuz AS; Panse J; Christen D; Heizmann M; Shoumariyeh K; Müller S; Elena C; Malcovati L; Fiorelli N; Wortmann F; Vucinic V; Brockow K; Fokoloros C; Papageorgiou SG; Breynaert C; Bullens D; Doubek M; Ilerhaus A; Angelova-Fischer I; Solomianyi O; Várkonyi J; Sabato V; Rüfer A; Schug TD; Hermans MAW; Fortina AB; Caroppo F; Bumbea H; Gulen T; Hartmann K; Elberink HO; Schwaab J; Arock M; Valent P; Sperr WR; Gotlib J
Blood Adv; 2023 May; 7(9):1713-1724. PubMed ID: 36094848
[TBL] [Abstract] [Full Text] [Related]
19. Therapy-related clonal cytopenia as a precursor to therapy-related myeloid neoplasms.
Shah MV; Mangaonkar AA; Begna KH; Alkhateeb HB; Greipp P; Nanaa A; Elliott MA; Hogan WJ; Litzow MR; McCullough K; Tefferi A; Gangat N; Patnaik MM; Al-Kali A; He R; Chen D
Blood Cancer J; 2022 Jul; 12(7):106. PubMed ID: 35803921
[TBL] [Abstract] [Full Text] [Related]
20. A novel heptasomy 21 associated with complete loss of heterozygosity and loss of function RUNX1 mutation in acute myeloid leukemia.
Yang F; Akkari Y; Fan G; Olson S; Moore S
Cancer Genet; 2022 Aug; 266-267():69-73. PubMed ID: 35802949
[TBL] [Abstract] [Full Text] [Related]
[Next]